Back

Value of PET and CMR in predicting ventricular arrhythmias in patients with ischaemic cardiomyopathy and implantable cardioverter-defibrillators

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Rapid Fire 4: The shocking truth of device therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Mischa Rijnierse

Jeroen Bosch Hospital, 's-Hertogenbosch (Netherlands (The))

9 More presentations in this session

Presentation thumbnail
Refining ICD decision-making in non-ischaemic patients in the post-DANISH era: analysis from a nationwide database of daily remote-monitoring transmissions in a real-world cohort
Doctor G. Forleo (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Long-term performance of contemporary internal cardioverter defibrillator leads: a single center experience
Doctor R. Brenner (St. Gallen, CH)
Abstract Slides Video
Presentation thumbnail
Incidence of appropriate therapy and mortality after ICD generator replacement: results from a real-world nationwide prospective cohort
Doctor M. Ruwald (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Myocardial damage as a result of implantation and defibrillation testing in transvenous and subcutaneous implantable cardioverter-defibrillators.
Ms A. Quast (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Depression and anxiety during the first 12 months post-implant: a matched cohort study of patients with a subcutaneous implantable defibrillator and patients with a transvenous system
Professor S. Schmidt Pedersen (Odense, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid Fire 4: The shocking truth of device therapy

The Event

Event poster

EHRA 2019

17 March - 19 March 2019
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources